A "Bella Infusion," based on available information, is likely referring to an intravenous infusion of NULOJIX® (belatacept), a prescription medicine used to prevent kidney transplant rejection in adults.
Here's a breakdown of what that entails:
-
Purpose: To prevent the body from rejecting a newly transplanted kidney. The immune system naturally recognizes the new kidney as foreign and tries to attack it. Belatacept helps suppress this immune response.
-
Mechanism: Belatacept works by blocking specific signals that activate T-cells, a type of immune cell responsible for attacking foreign substances. By blocking these signals, it prevents the T-cells from attacking the transplanted kidney.
-
Administration: Belatacept is administered intravenously, meaning it's given directly into a vein through an infusion.
-
Combination Therapy: Belatacept is typically used in combination with other immunosuppressant medications, such as corticosteroids. This multi-drug approach helps to provide comprehensive protection against rejection.
-
Important Considerations:
- Belatacept is not suitable for everyone. Patients need to be carefully evaluated to determine if it's the right treatment option for them.
- As an immunosuppressant, belatacept can increase the risk of infections and certain types of cancer. Patients need to be monitored closely for these potential side effects.
In conclusion, a "Bella Infusion" likely refers to the administration of belatacept, a medication used to prevent kidney transplant rejection, via intravenous infusion. It's a component of a larger immunosuppressant regimen aimed at protecting the transplanted organ.
